NASDAQ
Dianthus Therapeutics, Inc. (DNTH) has a current ratio of 13.32x as of Monday, May 25, 2026. This represents a 11.56% decrease compared to its 12-month average of 15.06x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.